JIPMER launches App for Eyelid injuries

Published On 2017-11-16 08:40 GMT   |   Update On 2021-08-20 06:04 GMT

Puducherry: The Jawharlal Institute of Post Graduate Medical Education and Research (JIPMER) launched an app called 'SPOT Eye' for Eyelid injuries.


According to a Jipmer release, Dr S C Parija, Director, Jipmer launched the app in the presence of Medical Superintendent Dr Badhe and Deputy Director Dr Patro.
Dr Parija said that, the purpose of this App is to help patients of Eyelid Injuries to classify & manage them properly as Jipmer receives regularly many cases of eyelid injuries in the casualty.


''There is no classification system for eyelid injuries in medical literature. This is the first classification of its kind developed by Jipmer,'' he said.


He further said that an 'App Committee' will be formed in JIPMER to encourage faculty & residents of Jipmer to develop more Apps for better patient care.


The App was developed by a team of Doctors from Department of Plastic Surgery with the help of Software Engineers--Prem Prakash Sahoo and Balakrishna V from Bangalore.


The App was first developed by Dr Devi Prasad Mohapatra from Dept of Plastic Surgery in the form of Classification which was published in Indexed Journal. To make easy to use and user friendly it was converted into an App. To make it free of cost & easy to use it is launched in android platform commonly used by all.


Officer Incharge of Patent Cell of Innovation Unit of Jipmer Dr Ravi Kumar Chittoria said that being a copyright of Jipmer it will be officially applied for patent & copyright through Jipmer Innovation Unit.


Head of the Department of Plastic Surgery Dr Dinesh Kumar S said that subsequently this App will be revised with more information and clinical photographs. The programme of release of this App was attended by faculty, staff and students of JIPMER.

Tags:    
Article Source : UNI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News